$MSCI

Are Wall Street Analysts Bullish on MSCI Stock?

MSCI Inc. (MSCI), a data and analytics provider, has underperformed the broader market over the past year. Its shares fell 10.1% on July 21 after raising its 2026 operating expense forecast, citing higher costs. Analysts expect MSCI's adjusted EPS to grow 13.5% YoY to $19.61. The consensus rating is 'Strong Buy' with a mean price target of $690.44, a 22.5% premium to current levels.

Original reporting
Published Aug 25, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Are Wall Street Analysts Bullish on MSCI Stock? — source image
Decision brief

The 30-second read

$MSCIBearishHigh
01

Why it matters

The guidance lift raises concerns about margin compression, prompting a sell‑off and a lower price target from JPMorgan. Traders may consider short positions or wait for cost‑control updates.

02

Market read

The news directly affects MSCI's stock price and may influence sentiment toward the broader financial‑data sector.

03

What to watch

Potential upside from upcoming index product launches or fee‑based revenue growth not captured in the expense forecast.

Relevance 8/10Novelty 8/10Timing: post‑July 21 expense‑forecast update

Background

MSCI is a leading provider of investment data, analytics, and indexes. The company recently reported a higher‑than‑expected operating expense forecast for 2026, triggering a share decline and analyst target revisions.

Company-level read

Ticker impact

$MSCIBearishHigh confidence
Context

MSCI shares fell 10.1% on July 21 after the company raised its 2026 operating expense forecast, and JPMorgan cut its price target to $700.

Expected impact

Further downside pressure if expense guidance remains above expectations; potential bounce if cost control measures are announced.

Evidence & confidence

A double‑digit intraday move combined with a fresh analyst target cut reflects material new information for a $41B cap stock.

Market effects

Higher expense outlook may pressure other data‑analytics and index providers as investors reassess cost structures.

Primarily U.S. equity market, with limited broader regional effect.

MSCI's indexes are globally used, so cost concerns could influence fund managers worldwide.

Counterpoint

If the expense increase is temporary and revenue growth accelerates, the stock could rebound, making the dip a buying opportunity.

Key entities

  • MSCI Inc.

    Provider of investment data, analytics, and indexes.

  • JPMorgan

    Reduced MSCI price target to $700 following expense forecast raise.

Related articles

$MSTRMed

MicroStrategy Bitcoin: MSCI Index Review Could Pressure Shares

MSCI is reviewing rules that could remove MicroStrategy from global equity indexes, focusing on companies primarily engaged in asset accumulation. MicroStrategy shares rose 35% in a week but are down 60% year-over-year. The review uses five financial metrics to assess eligibility, potentially affecting demand and capital access for MicroStrategy's Bitcoin purchases.

$MSTRMed

Bitcoin: MSCI Wants To eject Strategy From Its Global Indices

MSCI plans to revise its global index methodology to identify “non-operating” companies using five balance-sheet and cash-flow ratios, potentially removing Strategy (MSTR) from indices. MSCI simulations using May 2026 data suggest three removals: Strategy, Yellow Cake, and Metaplanet. Strategy challenged MSCI on Aug. 14 and has over 840,000 BTC. MSCI seeks comments until Sept. 30, 2026.

$MSTRMedAI 8/10

MSCI Wants Bitcoin Giant Strategy Out: $2 Billion Is on the Line

MSCI opened an Aug 14, 2026 consultation to exclude “non-operating” companies from its Global Investable Market Indexes, using May 2026 data. The proposal would delete Strategy (MSTR), Metaplanet (3350) and Yellow Cake (YCA) from the MSCI ACWI IMI, with feedback due Sep 30 and results Oct 16. Passive outflows are estimated up to $2.8B, or $8.8B if adopted broadly.

$MSTRMed

MicroStrategy sends harsh response to fresh MSCI delisting threat

MSCI opened a consultation on whether non-operating companies qualify for its Global Investable Market Indexes. A simulation using May 2026 data could remove Strategy (formerly MicroStrategy), Metaplanet, and Yellow Cake from the MSCI ACWI IMI, with others on a watchlist. MSCI plans results by Oct. 16; Strategy said the proposal is inappropriate. MSTR was $92.67, down 4.5% on the day.